BCIM
NVAX icon

British Columbia Investment Management’s Novavax NVAX Stock Holding History

British Columbia Investment Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,087
Closed -$817K – 847
2022
Q1 		$817K Sell
11,087
-1,366
-11% -$122K 0.01% 794
2021
Q4 		$1.78M Sell
12,453
-573
-4% -$98.5K 0.01% 720
2021
Q3 		$2.7M Sell
13,026
-76
-0.6% -$16.8K 0.02% 617
2021
Q2 		$2.78M Buy
+13,102
New +$2.4M 0.02% 627

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

British Columbia Investment Management's NVAX Position: Q2 2022 in Review

British Columbia Investment Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 11,087 shares — an estimated $817K sold.

British Columbia Investment Management first reported a position in NVAX in Q2 2021 and held it in 4 quarters. The position peaked at $2.78M in Q2 2021. 326 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • British Columbia Investment Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • British Columbia Investment Management sold 11,087 Novavax shares in Q2 2022, an estimated $817K.
  • British Columbia Investment Management first reported a position in Novavax in Q2 2021 and held it in 4 quarters.
  • British Columbia Investment Management's Novavax position peaked at $2.78M in Q2 2021.
  • 326 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on British Columbia Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.